Japanese distributor liable over diabetes products

A Chinese-owned developer of products for diabetes sufferers has applied to a US court to enforce a US$22.6 million ICC award against its Japanese former parent company concerning a terminated distribution deal.


Get unlimited access to all Global Arbitration Review content